- New Purchases: HUM, BMRN, VTRS, MRK, MCK, SMG, BAX, CVS, JAZZ, INMD, XBI, TCNNF, CI, VRNOF, UNH,
- Added Positions: THC, CERS, BVS, SIBN, GTBIF, PLXS,
- Reduced Positions: HSIC, PDCO, PRGO, MDT, UTHR, RIGL, ITGR, PCRX, ELY, MDRX, VRAY, RDNT, TPB, AHCO, ATRC, LNTH, TRSSF, ISEE, ANGO,
- Sold Out: MSON, ICUI, STE, TALK, DMTK, NVST,
For the details of Tamarack Advisers, LP's stock buys and sells, go to https://www.gurufocus.com/guru/tamarack+advisers%2C+lp/current-portfolio/portfolio
These are the top 5 holdings of Tamarack Advisers, LP- Tenet Healthcare Corp (THC) - 200,000 shares, 6.75% of the total portfolio. Shares added by 166.67%
- Pacira BioSciences Inc (PCRX) - 240,000 shares, 5.96% of the total portfolio. Shares reduced by 36%
- Medtronic PLC (MDT) - 125,000 shares, 5.34% of the total portfolio. Shares reduced by 37.5%
- Bioventus Inc (BVS) - 875,000 shares, 5.23% of the total portfolio. Shares added by 82.29%
- SI-BONE Inc (SIBN) - 550,000 shares, 5.04% of the total portfolio. Shares added by 37.50%
Tamarack Advisers, LP initiated holding in Humana Inc. The purchase prices were between $384.96 and $469.02, with an estimated average price of $443.48. The stock is now traded at around $423.960000. The impact to a portfolio due to this purchase was 3.83%. The holding were 20,000 shares as of 2021-12-31.
New Purchase: Biomarin Pharmaceutical Inc (BMRN)Tamarack Advisers, LP initiated holding in Biomarin Pharmaceutical Inc. The purchase prices were between $71.72 and $91.47, with an estimated average price of $82.84. The stock is now traded at around $91.280000. The impact to a portfolio due to this purchase was 3.28%. The holding were 90,000 shares as of 2021-12-31.
New Purchase: Viatris Inc (VTRS)Tamarack Advisers, LP initiated holding in Viatris Inc. The purchase prices were between $12.09 and $14.68, with an estimated average price of $13.35. The stock is now traded at around $15.185000. The impact to a portfolio due to this purchase was 2.79%. The holding were 500,000 shares as of 2021-12-31.
New Purchase: Merck & Co Inc (MRK)Tamarack Advisers, LP initiated holding in Merck & Co Inc. The purchase prices were between $72.28 and $90.54, with an estimated average price of $79.6. The stock is now traded at around $76.470000. The impact to a portfolio due to this purchase was 2.22%. The holding were 70,000 shares as of 2021-12-31.
New Purchase: McKesson Corp (MCK)Tamarack Advisers, LP initiated holding in McKesson Corp. The purchase prices were between $198.21 and $248.9, with an estimated average price of $220.27. The stock is now traded at around $273.845000. The impact to a portfolio due to this purchase was 2.05%. The holding were 20,000 shares as of 2021-12-31.
New Purchase: The Scotts Miracle Gro Co (SMG)Tamarack Advisers, LP initiated holding in The Scotts Miracle Gro Co. The purchase prices were between $134 and $176.89, with an estimated average price of $155.09. The stock is now traded at around $144.420000. The impact to a portfolio due to this purchase was 1.99%. The holding were 30,000 shares as of 2021-12-31.
Added: Tenet Healthcare Corp (THC)Tamarack Advisers, LP added to a holding in Tenet Healthcare Corp by 166.67%. The purchase prices were between $61.02 and $81.91, with an estimated average price of $73.32. The stock is now traded at around $82.465000. The impact to a portfolio due to this purchase was 4.22%. The holding were 200,000 shares as of 2021-12-31.
Added: Cerus Corp (CERS)Tamarack Advisers, LP added to a holding in Cerus Corp by 1233.33%. The purchase prices were between $5.97 and $7.93, with an estimated average price of $6.75. The stock is now traded at around $5.415000. The impact to a portfolio due to this purchase was 2.6%. The holding were 1,000,000 shares as of 2021-12-31.
Added: Bioventus Inc (BVS)Tamarack Advisers, LP added to a holding in Bioventus Inc by 82.29%. The purchase prices were between $12.37 and $16.77, with an estimated average price of $14.19. The stock is now traded at around $12.337500. The impact to a portfolio due to this purchase was 2.36%. The holding were 875,000 shares as of 2021-12-31.
Added: SI-BONE Inc (SIBN)Tamarack Advisers, LP added to a holding in SI-BONE Inc by 37.50%. The purchase prices were between $18.75 and $24.8, with an estimated average price of $21.51. The stock is now traded at around $20.730000. The impact to a portfolio due to this purchase was 1.37%. The holding were 550,000 shares as of 2021-12-31.
Added: Green Thumb Industries Inc (GTBIF)Tamarack Advisers, LP added to a holding in Green Thumb Industries Inc by 650.00%. The purchase prices were between $18.38 and $27.11, with an estimated average price of $22.03. The stock is now traded at around $20.800000. The impact to a portfolio due to this purchase was 0.6%. The holding were 75,000 shares as of 2021-12-31.
Sold Out: (MSON)Tamarack Advisers, LP sold out a holding in . The sale prices were between $24.89 and $26.54, with an estimated average price of $25.68.
Sold Out: ICU Medical Inc (ICUI)Tamarack Advisers, LP sold out a holding in ICU Medical Inc. The sale prices were between $220.96 and $247.44, with an estimated average price of $233.71.
Sold Out: Steris PLC (STE)Tamarack Advisers, LP sold out a holding in Steris PLC. The sale prices were between $206.02 and $245.17, with an estimated average price of $228.98.
Sold Out: Talkspace Inc (TALK)Tamarack Advisers, LP sold out a holding in Talkspace Inc. The sale prices were between $1.84 and $3.95, with an estimated average price of $2.82.
Sold Out: DermTech Inc (DMTK)Tamarack Advisers, LP sold out a holding in DermTech Inc. The sale prices were between $15.79 and $33.77, with an estimated average price of $23.75.
Sold Out: Envista Holdings Corp (NVST)Tamarack Advisers, LP sold out a holding in Envista Holdings Corp. The sale prices were between $37.73 and $46.74, with an estimated average price of $41.18.
Here is the complete portfolio of Tamarack Advisers, LP. Also check out:
1. Tamarack Advisers, LP's Undervalued Stocks
2. Tamarack Advisers, LP's Top Growth Companies, and
3. Tamarack Advisers, LP's High Yield stocks
4. Stocks that Tamarack Advisers, LP keeps buying